Prediction of short-term antidepressant response using probabilistic graphical models with replication across multiple drugs and treatment settings

Arjun P. Athreya, Tanja Brückl, Elisabeth B. Binder, A. John Rush, Joanna Biernacka, Mark A. Frye, Drew Neavin, Michelle Skime, Ditlev Monrad, Ravishankar K. Iyer, Taryn Mayes, Madhukar Trivedi, Rickey E. Carter, Liewei Wang, Richard M. Weinshilboum, Paul E. Croarkin, William V. Bobo

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Abstract

Heterogeneity in the clinical presentation of major depressive disorder and response to antidepressants limits clinicians’ ability to accurately predict a specific patient’s eventual response to therapy. Validated depressive symptom profiles may be an important tool for identifying poor outcomes early in the course of treatment. To derive these symptom profiles, we first examined data from 947 depressed subjects treated with selective serotonin reuptake inhibitors (SSRIs) to delineate the heterogeneity of antidepressant response using probabilistic graphical models (PGMs). We then used unsupervised machine learning to identify specific depressive symptoms and thresholds of improvement that were predictive of antidepressant response by 4 weeks for a patient to achieve remission, response, or nonresponse by 8 weeks. Four depressive symptoms (depressed mood, guilt feelings and delusion, work and activities and psychic anxiety) and specific thresholds of change in each at 4 weeks predicted eventual outcome at 8 weeks to SSRI therapy with an average accuracy of 77% (p = 5.5E-08). The same four symptoms and prognostic thresholds derived from patients treated with SSRIs correctly predicted outcomes in 72% (p = 1.25E-05) of 1996 patients treated with other antidepressants in both inpatient and outpatient settings in independent publicly-available datasets. These predictive accuracies were higher than the accuracy of 53% for predicting SSRI response achieved using approaches that (i) incorporated only baseline clinical and sociodemographic factors, or (ii) used 4-week nonresponse status to predict likely outcomes at 8 weeks. The present findings suggest that PGMs providing interpretable predictions have the potential to enhance clinical treatment of depression and reduce the time burden associated with trials of ineffective antidepressants. Prospective trials examining this approach are forthcoming.

Original languageEnglish (US)
Pages (from-to)1272-1282
Number of pages11
JournalNeuropsychopharmacology
Volume46
Issue number7
DOIs
StatePublished - Jun 2021

ASJC Scopus subject areas

  • Pharmacology
  • Psychiatry and Mental health

Fingerprint

Dive into the research topics of 'Prediction of short-term antidepressant response using probabilistic graphical models with replication across multiple drugs and treatment settings'. Together they form a unique fingerprint.

Cite this